Blood Culture Tests Market Share

  • Report ID: 4851
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Blood Culture Tests Market Share

APAC Market Forecast

The blood culture tests market share in Asia Pacific is estimated to cross more than 33% by 2037. Blood culture is currently the accepted method of diagnosis for possible bacteremia in the region. If bacteremia is suspected in a majority of high-income countries, blood cultures are often provided to patients with fever. Nevertheless, when working under resource constraints, physicians may decide to give patients direct treatment due to a lack of or limited laboratory capacities. In the present era of increasing antibiotic resistance, particularly in South Asia, blood cultures are becoming a more important tool to help identify the best course of therapy and promote effective management.

North American Market Statistics

The blood culture tests market in the North American region is set to grow substantially by reaching 31% share by the end of 2037. Rising demand for antimicrobial susceptibility testing awaits the blood culture testing market in the region. The most effective treatment for patients with bloodstream infections depends largely on the rapid identification of blood culture isolates and the conclusions of his AST. The importance of blood cultures is highlighted in the area by the fact that empiric antibiotic dosing is often inappropriate, leading to increased morbidity and mortality, prolonged hospital stays, and associated healthcare costs. Additionally, in September 2023, FDA issued a regulation entitled “Antibiotic Susceptibility Testing System Devices – Updates to Breakpoints in Device Labeling,” effective immediately.

Research Nester
Blood Culture Test Market size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4851
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood culture tests is evaluated at USD 7.27 billion.

Blood Culture Tests Market size was valued at USD 6.64 billion in 2024 and is projected to exceed USD 28.31 billion by the end of 2037, expanding at over 11.8% CAGR during the forecast period i.e., between 2025-2037. The growing cases of HAI and growth strategies by market players will drive the market growth.

Asia Pacific industry is estimated to hold largest revenue share of 33% by 2037, as blood cultures are becoming a more important tool to help identify the best course of therapy and promote effective management.

The major players in the market are of F. Hoffmann-La Roche AG, Cepheid, Scenker Biological Technology Co., Ltd, Bio-Rad Laboratories, Inc., TERUMO BCT, INC., bioMérieux SA, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample